10 Israeli Startups Changing the Tech Landscape in 2026
Israel remains one of the world’s most influential startup ecosystems, particularly in sectors where deep technical expertise, cybersecurity, artificial intelligence and scientific research intersect. Despite operating through an increasingly complex geopolitical and economic environment, the country’s technology sector has continued to attract global capital and produce companies addressing some of the biggest emerging opportunities in enterprise AI, cyber defense, biotechnology, data infrastructure and advanced software.
The Israel Innovation Authority reported that Israeli high-tech companies raised approximately $14.6 billion in 2025, a 30% increase from the previous year, while early 2026 continued to show strong fundraising momentum, with approximately $3.36 billion raised in the first quarter. The companies featured in this list demonstrate the range of technologies currently emerging from Israel’s startup ecosystem.
Some are building AI infrastructure for large enterprises, while others are using artificial intelligence to transform cybersecurity, drug discovery, data engineering and digital operations. Several have raised major rounds in 2026 and are already expanding internationally, while others are earlier-stage companies operating in highly specialized technology markets.
This is not a ranking based on valuation, funding or revenue. Instead, these ten companies represent a selection of Israeli technology startups whose products, investment momentum, technical ambitions or commercial opportunities make them particularly worth watching in 2026.

10 Israeli Tech Startups to Watch in 2026
1. Wonderful
Wonderful is an enterprise artificial intelligence company founded in 2025 and building what it describes as an AI operating system for large organizations. Led by co-founder and CEO Bar Winkler and co-founder and CTO Roey Lalazar, Wonderful combines a multi-model AI platform with locally embedded deployment teams that work directly with enterprises to move AI applications from experimentation into production.
Its technology has evolved beyond its original focus on conversational AI agents for customer-facing use cases into a broader platform capable of automating end-to-end workflows, supporting employees with productivity agents, building AI-native applications and coordinating multiple agents across an organization. Wonderful’s approach is designed for large and often highly regulated industries, including telecommunications, banking, healthcare, insurance, utilities and retail, where integrating AI into existing infrastructure can be as difficult as developing the AI itself.
The company has experienced extraordinary funding momentum during 2026. In March, Wonderful raised a $150 million Series B led by Insight Partners at a $2 billion valuation, with participation from Index Ventures, IVP, Bessemer Venture Partners and Vine Ventures. Its growth accelerated further in September 2026, when Wonderful announced a $550 million Series C at a $5 billion valuation, again led by Insight Partners and joined by Salesforce alongside existing investors.
The company said it was operating across more than 35 markets and had grown to approximately 650 employees. With enterprise AI increasingly moving from isolated pilots toward organization-wide transformation, Wonderful is positioning itself not simply as another AI agent provider, but as infrastructure intended to become part of how large companies operate.
2. Dream
Dream is an Israeli sovereign AI and cybersecurity company focused on protecting governments and critical infrastructure from increasingly sophisticated digital threats. Founded in 2023 by former NSO Group CEO Shalev Hulio, former Austrian Chancellor Sebastian Kurz and entrepreneur Gil Dolev, Dream is building technology around the concept of cyber sovereignty, helping governments and national infrastructure operators develop greater visibility, control and defensive capabilities against cyberattacks.
The company’s flagship sovereign AI platform, Atlas, is designed to protect critical systems and infrastructure from advanced attacks, including threats associated with nation-state actors. Dream’s focus distinguishes it from many conventional cybersecurity startups because its target customers include governments and organizations responsible for strategically important infrastructure such as energy, water and other national systems.
The company has expanded rapidly since beginning commercial operations in late 2024 and reported nearly $300 million in total contract value from customers across Europe, the Middle East and Asia. Dream reached a major milestone in June 2026 when it announced a $260 million funding round that valued the company at $3 billion. The financing was co-led by Bicycle Capital and Group 11, with participation from Antler, Bain Capital Ventures, Tru Arrow Partners and other investors. The capital is intended to support the global deployment of Dream’s sovereign AI and national cyber-defense platforms across Europe, the Middle East, Asia and the Americas.
As cyber threats become increasingly connected to geopolitical competition and AI makes both attacks and defenses more sophisticated, Dream is operating in a rapidly expanding market where governments are likely to become increasingly important technology customers.
3. Onyx
Onyx Security is a cybersecurity company developing what it calls a secure AI control plane for the agentic era, giving enterprises greater visibility and control over autonomous AI systems. Founded in 2024 by CEO Maxim Bar Kogan and Chief AI Officer Gil Elbaz, the company is addressing a new security problem created by the rapid adoption of AI agents. Unlike traditional software, agents can reason, access sensitive information, connect with external tools and take actions with varying degrees of autonomy, creating operational and cybersecurity risks that conventional security systems were not designed to manage.
Onyx’s platform is designed to discover AI agents and related assets across an organization, monitor their behavior and enforce controls before potentially unsafe actions are executed. The company says its platform allows security, governance and infrastructure teams to oversee AI adoption without forcing enterprises to slow their deployment of autonomous systems.
Onyx emerged from stealth in March 2026 with $40 million in seed and Series A financing backed by Conviction and Cyberstarts, while already serving multiple Fortune 500 customers and employing more than 70 people across Israel, the United States and Canada. Its momentum accelerated rapidly.
In July 2026, Onyx announced a $113 million Series B led by Bessemer Venture Partners, with participation from Cyberstarts, TCV, Conviction, FirstMark, Vintage, QuantumLight and G Squared, bringing total funding to $153 million. The company also reported that revenue had quadrupled since its public launch only four months earlier.
As enterprises increasingly deploy hundreds or potentially thousands of AI agents, the question of who monitors those systems and how they are controlled could become one of the defining cybersecurity challenges of the AI era.
4. Vega
Vega is an Israeli cybersecurity company developing an agentic platform designed to help organizations detect, investigate and respond to cyber threats more efficiently. Founded in 2024 by Shay Sandler and Eli Rozen, the company was established by former members of Granulate and graduates of Israel’s Unit 8200, bringing together experience in cybersecurity, cloud infrastructure and large-scale software systems.
Vega’s approach is built around using AI to automate significant parts of the security investigation process. Rather than relying solely on conventional security tools that collect and centralize large volumes of telemetry, Vega is developing technology that can work directly with data stored across an organization’s environment and help security teams identify suspicious activity and determine what requires attention. The company’s platform is designed to give security teams greater context around potential threats while reducing the amount of manual analysis required from security professionals.
The company has attracted considerable investor interest for such a young cybersecurity startup. By early 2026, Vega had raised approximately $185 million across three funding rounds and reached a valuation of roughly $800 million. Its rapid financing reflects growing investor interest in AI-native cybersecurity companies, particularly those attempting to use autonomous systems to address the increasing volume and complexity of cyber threats.
Vega’s opportunity comes at a time when traditional security operations are facing a difficult combination of expanding attack surfaces, increasingly sophisticated attackers and a shortage of skilled cybersecurity professionals. AI could allow security teams to investigate incidents faster and automate tasks that previously required significant analyst involvement. However, the challenge for companies such as Vega is proving that autonomous security systems can operate reliably in production environments without introducing additional risks.
As enterprises increasingly experiment with AI agents and autonomous software, cybersecurity is becoming an even more important part of the AI infrastructure stack. Vega is therefore worth watching in 2026 not simply because of its rapid fundraising, but because it is attempting to apply agentic AI to one of the technology industry’s most persistent problems: helping security teams identify and respond to threats at a scale that human analysts alone cannot easily manage.
5. Airis
Airis Labs is an Israeli defense technology company developing artificial intelligence systems that turn fragmented visual information into actionable intelligence. Founded in 2023 by Noam Friedman, Rotem Abeles and Amos Lahav, the company is building what it describes as a visual-intelligence platform for defense and national-security organizations. Its technology is designed to process information from sources including smartphones, drones, CCTV systems, body cameras and social media, helping organizations make sense of large volumes of visual data that would otherwise be difficult to analyze manually.
The problem Airis is addressing is becoming increasingly important as modern military and security operations generate enormous quantities of visual information. Analysts may need to examine footage and imagery from many different sources while attempting to identify objects, events, people and other potentially significant details. Airis aims to use AI to automate much of this analysis and connect information from disparate sources into a more comprehensive intelligence picture.
The company’s technology sits at the intersection of artificial intelligence, computer vision and defense intelligence, an area that has attracted growing attention as militaries and security agencies look for ways to process information faster. Rather than positioning AI simply as a tool for generating text or assisting individual users, Airis is applying it to operational environments where the ability to extract useful intelligence from large quantities of visual information can have significant consequences.
Airis has also demonstrated substantial investor momentum. The company emerged from stealth in 2026 with a $31 million Series B, providing capital to expand its technology and customer base. Its international footprint, including operations in Tel Aviv and Washington, D.C., reflects the global nature of the defense and national-security market it is targeting.
Airis is worth watching because the role of AI in defense is expanding beyond autonomous systems and weapons technology toward the intelligence layer that helps organizations understand what is happening in increasingly complex environments. If Airis can reliably turn disparate visual feeds into useful, real-time intelligence, its technology could become an important component of the emerging AI-enabled defense ecosystem.
6. Remepy
Remepy is an Israeli health-tech company developing a new approach to medicine that combines conventional pharmaceutical treatments with targeted digital interventions. The company calls these combinations “Hybrid Drugs,” with the goal of using software-based interventions alongside existing medicines to improve treatment outcomes. Founded in 2021 and headquartered in Tel Aviv, Remepy is led by co-founder and CEO Alon Litskevich and is focused initially on neurological and other complex diseases where medication alone may not address every aspect of a patient’s condition.
The company’s most advanced program is Hybridopa, a treatment approach for Parkinson’s disease that combines levodopa, a standard medication used to manage Parkinson’s symptoms, with a digital intervention designed to complement the drug’s effects. Rather than treating software as a separate digital-health product, Remepy is attempting to integrate the digital component directly into the therapeutic model and evaluate the combined treatment through clinical development.
This approach addresses an important challenge in modern medicine: pharmaceutical treatments can be effective at targeting biological mechanisms while leaving behavioral, functional or symptom-management challenges that may require additional forms of intervention. Remepy believes carefully designed digital components can potentially extend or enhance the impact of established medicines while generating additional data about how patients respond to treatment.
Remepy attracted significant investor interest as it advanced its technology toward larger-scale clinical development. In August 2026, the company announced a $36 million Series A, bringing its total funding to approximately $62 million. The financing is intended to support the continued development of Hybridopa and the company’s broader Hybrid Drug pipeline, including preparations for later-stage clinical development.
Remepy’s opportunity sits at the intersection of biotechnology, digital health and artificial intelligence-enabled medicine. While many digital-health companies focus on standalone software applications, Remepy is pursuing a different model in which software becomes part of the therapeutic intervention itself. If its clinical programs demonstrate that these Hybrid Drugs can produce meaningful benefits beyond conventional pharmaceutical treatment, the company could help establish a new category of technology-enabled medicine.
7. Scala Biodesign
Scala Biodesign is a Tel Aviv-based computational biology company developing AI-powered software to help pharmaceutical and biotechnology companies design and optimize proteins. Founded in 2022 and led by CEO Ravit Netzer, Scala is working in a field where advances in artificial intelligence could significantly accelerate the discovery and development of new biologic medicines, enzymes, antibodies and vaccines.
Its platform combines large language models, physics-based modeling and evolutionary data to help scientists evaluate and engineer proteins more efficiently. The problem Scala is addressing is particularly important because protein engineering remains a major bottleneck in drug development, with researchers often needing to test large numbers of potential designs before identifying candidates suitable for further development. Scala’s technology is designed to improve this process by helping scientists identify and optimize promising proteins earlier.
The company has already attracted significant commercial interest, with Axios reporting that nine of the world’s top 20 pharmaceutical companies were customers as of March 2026, including Boehringer Ingelheim. Scala reached an important financing milestone in March 2026 when it raised a $16 million Series A led by Grove Ventures. The round included TLV Partners, Deep Insight and the Israel Innovation Authority and brought the company’s total funding to approximately $21.5 million. The new capital is being used to expand Scala’s research and development capabilities and onboard additional customers.
Scala’s opportunity sits within the rapidly growing convergence of AI and life sciences. As pharmaceutical companies increasingly adopt computational tools to reduce the cost and time associated with drug discovery, companies capable of building reliable platforms for scientific workflows could become increasingly important infrastructure providers to the global biotech industry.
8. Matia
Matia is an Israeli-founded data infrastructure company building what it describes as a unified, AI-native platform for modern data teams. Founded by Benjamin Segal, who serves as co-founder and CEO, Matia is addressing a growing problem within organizations: data is increasingly distributed across multiple databases, warehouses, applications and cloud services, making it difficult for companies to build reliable pipelines and prepare information for analytics and artificial intelligence.
The company is developing infrastructure intended to simplify how data is moved, transformed and managed, with the longer-term ambition of building an AI data engineer capable of automating more of the work traditionally performed by specialist teams. Matia’s approach is particularly relevant as AI adoption increases the importance of reliable underlying data. Advanced models may be capable of sophisticated reasoning, but their usefulness inside enterprises still depends heavily on whether they can access accurate, well-structured and up-to-date information. Matia is therefore targeting the infrastructure layer beneath the AI applications themselves.
In February 2026, the company announced a $21 million Series A led by Red Dot Capital Partners, with participation from Leaders Fund, Secret Chord Ventures, Cerca Partners, Caffeinated Capital and VelocityX, alongside a group of technology executives and angel investors. The financing brought Matia’s total funding to more than $31 million. The company said the new capital would support its mission to build unified AI-native data infrastructure for modern data teams.
As enterprises increasingly attempt to connect AI systems with proprietary information and operational workflows, the companies making data more accessible and reliable could become essential parts of the broader AI technology stack.
9. Tenna
Tenna Systems is an Israeli defense-technology company developing artificial intelligence and software for electromagnetic-spectrum intelligence. Founded by brothers Avner Bendheim and Gabriel Bendheim together with Ronen Shatz, the company is focused on helping defense and security organizations understand increasingly complex radio-frequency environments, an area becoming more strategically important as modern military operations rely on drones, communications systems, electronic warfare and other technologies that operate across the electromagnetic spectrum.
Tenna’s platform is designed to collect and analyze radio-frequency signals and turn them into a real-time picture of activity within a particular electromagnetic environment. This can help operators identify, classify and monitor signals that may otherwise be difficult to interpret when large numbers of devices and transmissions are operating simultaneously. The company’s technology is therefore aimed at giving defense organizations greater visibility into an increasingly contested component of modern warfare.
The company attracted significant attention in 2026 when it emerged from stealth with a $13.5 million seed round led by Costanoa Ventures. The financing is being used to expand Tenna’s technology and support the company’s development as it targets defense and security customers in international markets.
Tenna’s opportunity is closely connected to the rapid growth of autonomous and connected military systems. Drones, unmanned vehicles, tactical communications and other networked technologies are increasing the number of signals that militaries must monitor, while electronic warfare has made control of the electromagnetic spectrum an increasingly important battlefield capability. Traditional approaches can struggle to provide operators with a sufficiently clear and timely picture of what is happening across that spectrum.
Tenna Systems is therefore worth watching as part of Israel’s growing defense-tech sector. Its focus is not on another conventional cybersecurity product, but on the intelligence layer surrounding the electromagnetic environment in which modern military and autonomous systems operate. If the company can translate its RF analysis technology into reliable operational capabilities at scale, it could become an important player in the increasingly software-defined and AI-enabled defense market.
10. Encore AI
Encore AI is an Israeli-founded enterprise AI company developing agents designed to turn customer interactions into measurable revenue. Founded in 2022 by Dr. Dvir Ginzburg, the company uses artificial intelligence to help businesses qualify leads, convert prospects, onboard customers, drive upselling and cross-selling, and recover lost revenue across customer interactions. While many enterprise AI platforms focus primarily on reducing support costs or deflecting customer-service requests, Encore is positioning its technology around the opposite objective: increasing the commercial value of each customer interaction.
At the center of Encore’s platform is its patented Interaction Mining technology. The system analyzes an organization’s customer-interaction data (including calls, chats, emails, funnel stages and CRM information) to identify the behaviors and tactics associated with its highest-performing employees. Encore then turns those patterns into adaptive AI agents that can either work alongside human representatives in real time or conduct customer journeys autonomously. The company’s platform supports multiple channels and is designed to operate in multiple languages, making it applicable to large enterprises with complex customer operations.
Encore has gained particular traction in highly regulated industries, including financial services. Its AI agents are designed for use cases such as lead qualification, customer onboarding, account opening, loan applications, cross-selling and customer recovery. The company argues that its advantage comes from learning directly from an organization’s existing interaction data rather than requiring businesses to build AI workflows entirely from scratch.
The company reached a major funding milestone in July 2026 when it raised $30 million in Series A funding, led by Team8, Planven and The Garage. Several commercial banks and insurers that had become Encore customers also participated in the round. The financing is being used to expand the global deployment of Encore’s enterprise AI platform.
Encore’s corporate footprint has also evolved as it has expanded internationally. Although the company was founded in Israel, its current headquarters are in New York, with a global presence across APAC and EMEA. This makes “Israeli-founded” a more accurate description than simply calling Encore an Israeli-headquartered startup.
Israel’s Next Tech Wave Is Becoming Increasingly AI-Native
The companies featured in this list highlight how Israel’s technology ecosystem is entering another important phase. Cybersecurity remains a defining strength, as companies such as Dream and Onyx demonstrate, but AI is now becoming deeply embedded across almost every category of technology. Wonderful is building enterprise-wide AI infrastructure, Scala Biodesign is applying AI to protein engineering and Matia is developing the data foundations required to make AI useful inside modern organizations.
The broader ecosystem continues to demonstrate remarkable resilience. Israeli high-tech companies raised approximately $14.6 billion in 2025, while the first quarter of 2026 saw approximately $3.36 billion in additional capital raised. At the same time, the ecosystem faces challenges including a more concentrated funding market and increasing competition for technical talent.
What remains clear, however, is Israel’s ability to produce companies built for global markets from their earliest stages. The next generation will increasingly be defined not only by cybersecurity expertise, but by the convergence of AI, scientific computing, data infrastructure and autonomous systems. The startups on this list offer an early look at companies attempting to shape that next chapter.

